Home / Learn / Oncology Pharmacy

Oncology Pharmacy

As oncology engages in value-based reimbursement, new payment models, and precision medicine, oncology pharmacists and pharmacy staff are integral to successful delivery of quality, cost-effective patient care.

The challenges are ongoing: increasing complexity of treatment regimens, new drug approvals and indications, the expansion of biosimilars in oncology, rapid advances in immunotherapy, the high cost of cancer treatment, and continual regulatory and reimbursement changes. 

The ACCC Oncology Pharmacy Education Network (OPEN) brings together education, resources, and peer-to-peer networking to help pharmacy professionals surmount the challenges and succeed.  OPEN offers the knowledge and know-how to navigate the accelerating course of change in oncology—clinically, operationally, fiscally, and programmatically. From USP <800> to integration of biosimilars, from preauthorizations to strategic planning—OPEN addresses real-world oncology pharmacy management issues such as reimbursement, distribution, inventory management, and effective integration of oral oncolytics, biosimilars, and immunotherapies for cancer.

Call for OPEN Task Force Members

The ACCC Oncology Pharmacy Education Network (OPEN) is seeking a multidisciplinary group of volunteers to serve in various leadership roles, including on the expert advisory committee which leads the initiative, as well as on mission-driven task-forces. Some positions require less time commitment than others, with an average commitment of 1-2 hours per quarter. The target dates of service range from the end of 2020 through 2022. 

The deadline to submit your application is Friday, November 5. We greatly appreciate your commitment to improving oncology pharmacy education and look forward to reading your entry.

Submit Application 


  • [PODCAST] Episode 22: Biosimilars—What Patients Need to Know
    Oct 20, 2020

    Miami Cancer Institute shares their unique approach to helping patients with cancer understand why biosimilars may be their best—and most cost-effective—option for treatment.

  • [PODCAST] Episode 18: Reducing Cancer Drug Waste
    Jul 28, 2020

    Learn about the ways cancer programs are working to reduce drug waste and curb the rising cost of cancer care.

  • [PODCAST] Mini-Podcast: COVID-19 & Oral Oncolytics
    Apr 14, 2020

    We explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.

  • [PODCAST] Episode 12: What's Trending in Cancer Care
    Feb 26, 2020

    Discover the results of the 2019 Trending Now in Cancer Care Survey—what tops the list of challenges, what areas are trending towards growth, and how cancer programs are evolving to meet the demands of 21st-century cancer care delivery.

  • [PODCAST] Episode 7: The Evolution of Oncology Pharmacy
    Oct 29, 2019
    Learn more about the role that oncology pharmacists play in cancer care and how that role is changing in the face of new therapies and the advent of value-based health. Discover how UNC Hospital's Department of Pharmacy avoids passing surprise bills to patients and ensures financial stability for their cancer program.

From Oncology Issues

  •  Highlights from a Virtual ASCO 2020
    Cary A. Presant, MD, FACP, FASCO
    Listed are my highlights of the ASCO 2020 abstracts, which were chosen if they were a practice-changing study or trial with important new advances.
  •  Reducing Revenue Loss and Patient Financial Toxicity with a Pharmacy-Managed Pre-Certification and Denials Management Program
    Suzanne J. Francart, PharmD, BCPS, et al.
    To adequately address patient financial toxicity, institutions must assume responsibility for ensuring that patients understand their insurance coverage and anticipated out-of-pocket expenses. Institutions should also have procedures in place to navigate the pre-certification process and prevent claim denials that may ultimately end up as the patient’s responsibility.
  •  The Year of the Biosimilar
    Ali McBride, PharmD, MS, BCOP
    With the advent of biologics decades ago, the practice of oncology was forever changed.
  •  The Emerging Role of Oral Oncolytics
    Ali McBride, PharmD, MS, BCOP
    Oral oncolytic agents have several advantages over the parenteral route, including patient convenience, prolonged drug exposure, and non-invasive administration.
  •  Chemotherapy Stewardship
    Ali McBride, PharmD, MS, BCOP
    In response to the increasing complexity of oncolytic agents, the associated economic burden on the patient and health system, and the intricacies associated with alternative payment models (APMs), I suggest the need for widespread establishment of chemotherapy stewardship services.

Additional Resources


Patient-Centered Scheduling: Costs & Benefits of Extending Practice Hours

This special report from ACCC examines the pros and cons of extended infusion suite hours. Included is a tool to help practices and programs assess the feasibility of extending hours of care.

Oral Chemotherapy

Dispensing Pharmacy Patient Education Tool

Physician dispensing is governed by state law and regulated by State Boards of Pharmacy. While some states do not allow physician dispensing, most of the states that allow it require dispensing physicians to alert their patients about other options to fill their prescription(s). In response to this need, ACCC has developed this patient education tool that can be used across care settings.

Upcoming Meetings


Oncology Drug Database

Access ACCC's comprehensive resource for coding, billing, and reimbursement for oncology drugs.
Access the Database

ACCCBuzz Blog Posts